CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
Standing +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03602482
NCT03602482N/ACompleted
CompareCT.gov

Standing Cognition and Co-morbidities of POTS Evaluation

Milton S. Hershey Medical Center·interventional·Posted Jul 26, 2018·Updated Apr 14, 2021

In Brief

A clinical study evaluating Standing and Supine for Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome. Completed, enrolled 139 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate cognition in patients with postural tachycardia syndrome (POTS) while lying down and standing and to assess the prevalence of hypermobile Ehlers-Danlos Syndrome in POTS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostural Tachycardia Syndrome, Ehlers-Danlos Syndrome
CountriesUnited States
CollaboratorsDysautonomia International

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 26, 2018
Enrollment StartJun 23, 2018
Primary CompletionDec 17, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.9 years ago

Interventions

Standingbehavioral

Participants will stand and complete cognitive tests.

Supinebehavioral

Participants will complete cognitive tests while supine.